BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578-1583. [PMID: 12873581 DOI: 10.1111/j.1572-0241.2003.07542.x] [Cited by in Crossref: 243] [Cited by in F6Publishing: 222] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, Kamm M. Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther. 2008;28:830-840. [PMID: 18637004 DOI: 10.1111/j.1365-2036.2008.03801.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
2 Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293-1301, 1301.e1-3. [PMID: 21745450 DOI: 10.1053/j.gastro.2011.06.074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
3 Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:48-53. [PMID: 18848909 DOI: 10.1016/j.cgh.2008.08.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
4 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: org/10.1016/j.bpg.2004.04.002] [Reference Citation Analysis]
5 Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am. 2010;24:961-975, ix. [PMID: 20937460 DOI: 10.1016/j.idc.2010.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
6 Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 5] [Article Influence: 42.0] [Reference Citation Analysis]
7 Chatoo M, Li Y, Ma Z, Coote J, Du J, Chen X. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome. Front Endocrinol (Lausanne) 2018;9:21. [PMID: 29483895 DOI: 10.3389/fendo.2018.00021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
8 Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, Autenrieth IB, Zipfel S, Frick JS. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011;23:e479-e488. [PMID: 21883703 DOI: 10.1111/j.1365-2982.2011.01779.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 53] [Article Influence: 6.7] [Reference Citation Analysis]
9 Choudhury BK, Shi XZ, Sarna SK. Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS. Am J Physiol Gastrointest Liver Physiol. 2009;296:G632-G642. [PMID: 19136376 DOI: 10.1152/ajpgi.90673.2008.epub] [Reference Citation Analysis]
10 Lakhan SE, Kirchgessner A. Gut microbiota and sirtuins in obesity-related inflammation and bowel dysfunction. J Transl Med 2011;9:202. [PMID: 22115311 DOI: 10.1186/1479-5876-9-202] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014;9:e93144. [PMID: 24667736 DOI: 10.1371/journal.pone.0093144] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
12 Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13:613-621. [PMID: 27667579 DOI: 10.1038/nrgastro.2016.141] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 17.5] [Reference Citation Analysis]
13 Robertson LJ, Hanevik K, Escobedo AA, Mørch K, Langeland N. Giardiasis--why do the symptoms sometimes never stop? Trends Parasitol 2010;26:75-82. [PMID: 20056486 DOI: 10.1016/j.pt.2009.11.010] [Cited by in Crossref: 128] [Cited by in F6Publishing: 106] [Article Influence: 11.6] [Reference Citation Analysis]
14 Bennet SMP, Polster A, Törnblom H, Isaksson S, Capronnier S, Tessier A, Le Nevé B, Simrén M, Öhman L. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 2016;111:1165-76. [DOI: 10.1038/ajg.2016.223] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
15 Kowalcyk BK, Smeets HM, Succop PA, De Wit NJ, Havelaar AH. Relative risk of irritable bowel syndrome following acute gastroenteritis and associated risk factors. Epidemiol Infect 2014;142:1259-68. [PMID: 23941625 DOI: 10.1017/S0950268813001891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Laing ST, Merriam D, Shock BC, Mills S, Spinner A, Reader R, Hartigan-O'Connor DJ. Idiopathic Colitis in Rhesus Macaques Is Associated With Dysbiosis, Abundant Enterochromaffin Cells and Altered T-Cell Cytokine Expression. Vet Pathol 2018;55:741-52. [PMID: 29929446 DOI: 10.1177/0300985818780449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
18 Bouchoucha M, Hejnar M, Devroede G, Babba T, Bon C, Benamouzig R. Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue? Clin Res Hepatol Gastroenterol. 2013;37:422-430. [PMID: 23270854 DOI: 10.1016/j.clinre.2012.10.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
19 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.v13.45.6041] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
20 Rijnierse A, Nijkamp FP, Kraneveld AD. Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome. Pharmacol Ther. 2007;116:207-235. [PMID: 17719089 DOI: 10.1016/j.pharmthera.2007.06.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 5.1] [Reference Citation Analysis]
21 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
22 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol. 2016;22:2242-2255. [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 40] [Article Influence: 12.8] [Reference Citation Analysis]
23 Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, Mäkivuokko H, Kajander K, Palva A. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009;9:95. [PMID: 20015409 DOI: 10.1186/1471-230X-9-95] [Cited by in Crossref: 175] [Cited by in F6Publishing: 117] [Article Influence: 14.6] [Reference Citation Analysis]
24 El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH, Hausken T. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept. 2014;188:60-65. [PMID: 24316398 DOI: 10.1016/j.regpep.2013.11.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
25 Torbicki E, Oh J, Mishra S, Page AV, Boggild AK. Interventions for post-infectious irritable bowel syndrome: a systematic review of treatment efficacy. Trop Dis Travel Med Vaccines 2015;1:1. [PMID: 28883933 DOI: 10.1186/s40794-015-0002-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yang PC, Jury J, Söderholm JD, Sherman PM, McKay DM, Perdue MH. Chronic psychological stress in rats induces intestinal sensitization to luminal antigens. Am J Pathol 2006;168:104-14; quiz 363. [PMID: 16400013 DOI: 10.2353/ajpath.2006.050575] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]
27 Leighton MP, Lam C, Mehta S, Spiller RC. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial. Trials. 2013;14:10. [PMID: 23302220 DOI: 10.1186/1745-6215-14-10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
28 Törnblom H, Holmvall P, Svenungsson B, Lindberg G. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults. Clin Gastroenterol Hepatol 2007;5:461-4. [PMID: 17445752 DOI: 10.1016/j.cgh.2007.01.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
29 Camilleri M. Pharmacology of the New Treatments for Lower Gastrointestinal Motility Disorders and Irritable Bowel Syndrome. Clin Pharmacol Ther 2011;91:44-59. [DOI: 10.1038/clpt.2011.261] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
30 Rodríguez-Fandiño OA, Hernández-Ruiz J, López-Vidal Y, Charúa-Guindic L, Escobedo G, Schmulson MJ. Maturation Phenotype of Peripheral Blood Monocyte/Macrophage After Stimulation with Lipopolysaccharides in Irritable Bowel Syndrome. J Neurogastroenterol Motil 2017;23:281-8. [PMID: 28044051 DOI: 10.5056/jnm16137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study. Scand J Gastroenterol. 2012;47:1159-1164. [PMID: 22783919 DOI: 10.3109/00365521.2012.694903] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
32 Fernández-blanco JA, Barbosa S, Sánchez de Medina F, Martínez V, Vergara P. Persistent epithelial barrier alterations in a rat model of postinfectious gut dysfunction: Postinfectious gut barrier dysfunction. Neurogastroenterology & Motility 2011;23:e523-33. [DOI: 10.1111/j.1365-2982.2011.01777.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
33 Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, Mccallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13192. [DOI: 10.1111/nmo.13192] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 13.5] [Reference Citation Analysis]
34 Gonçalves CC, Hernandes L, Bersani-Amado CA, Franco SL, Silva JF, Natali MR. Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid. Evid Based Complement Alternat Med 2013;2013:853976. [PMID: 24101941 DOI: 10.1155/2013/853976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
35 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: 10.1016/j.gtc.2005.02.007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
36 Pisipati S, Connor BA, Riddle MS. Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome. Curr Opin Infect Dis. 2020;33:411-418. [PMID: 32833689 DOI: 10.1097/qco.0000000000000666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Ahn JY, Lee KH, Choi CH, Kim JW, Lee HW, Kim JW, Kim MK, Kwon GY, Han S, Kim SE. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci. 2014;59:1001-1011. [PMID: 24282051 DOI: 10.1007/s10620-013-2930-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
38 Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A, Spiller RC. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology. 2011;140:1434-43.e1. [PMID: 21315720 DOI: 10.1053/j.gastro.2011.01.052] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
39 Löwe B, Lohse A, Andresen V, Vettorazzi E, Rose M, Broicher W. The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study. Am J Gastroenterol 2016;111:1320-9. [PMID: 27377523 DOI: 10.1038/ajg.2016.255] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
40 DuPont HL. New insights and directions in travelers' diarrhea. Gastroenterol Clin North Am 2006;35:337-53, viii-ix. [PMID: 16880069 DOI: 10.1016/j.gtc.2006.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
41 Dupont HL. Systematic review: prevention of travellers’ diarrhoea: SYSTEMATIC REVIEW: PREVENTION OF TRAVELLERS’ DIARRHOEA. Alimentary Pharmacology & Therapeutics 2008;27:741-51. [DOI: 10.1111/j.1365-2036.2008.03647.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
42 Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjövall H, Simrén M. B-cell activation in patients with irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2009;21:644-650, e27. [PMID: 19222763 DOI: 10.1111/j.1365-2982.2009.01272.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
43 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.1] [Reference Citation Analysis]
44 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-2393-13-201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
45 Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J. 2010;51:45-51. [PMID: 20046513 DOI: 10.3349/ymj.2010.51.1.45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
46 Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol. 2009;6:306-314. [PMID: 19404271 DOI: 10.1038/nrgastro.2009.35] [Cited by in Crossref: 609] [Cited by in F6Publishing: 527] [Article Influence: 50.8] [Reference Citation Analysis]
47 Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006;101:S602-9. [PMID: 17177863 DOI: 10.1111/j.1572-0241.2006.00975.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
48 Manabe N, Rao AS, Wong BS, Camilleri M. Emerging Pharmacologic Therapies for Irritable Bowel Syndrome. Curr Gastroenterol Rep 2010;12:408-16. [DOI: 10.1007/s11894-010-0124-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
49 Feng B, La JH, Schwartz ES, Gebhart GF. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1085-G1098. [PMID: 22403791 DOI: 10.1152/ajpgi.00542.2011] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 9.2] [Reference Citation Analysis]
50 El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 2014;8:435-443. [PMID: 24580043 DOI: 10.1586/17474124.2014.888952] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
51 Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55:716-723. [PMID: 19255843 DOI: 10.1007/s10620-009-0765-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
52 Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004;99:1774-1778. [PMID: 15330917 DOI: 10.1111/j.1572-0241.2004.30435.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 124] [Article Influence: 9.7] [Reference Citation Analysis]
53 Wouters MM, Farrugia G, Schemann M. 5-HT receptors on interstitial cells of Cajal, smooth muscle and enteric nerves. Neurogastroenterol Motil. 2007;19 Suppl 2:5-12. [PMID: 17620082 DOI: 10.1111/j.1365-2982.2007.00963.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
54 Tikoo S, Barki N, Jain R, Zulkhernain NS, Buhner S, Schemann M, Weninger W. Imaging of mast cells. Immunol Rev 2018;282:58-72. [PMID: 29431206 DOI: 10.1111/imr.12631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
55 DuPont AW. Postinfectious irritable bowel syndrome. Clin Infect Dis. 2008;46:594-599. [PMID: 18205536 DOI: 10.1086/526774] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
56 Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844-849. [PMID: 19716778 DOI: 10.1016/j.dld.2009.07.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
57 Hanevik K, Dizdar V, Langeland N, Hausken T. Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol. 2009;9:27. [PMID: 19383162 DOI: 10.1186/1471-230x-9-27] [Cited by in Crossref: 100] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
58 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
59 Marshall JK, Thabane M, Garg AX, Clark W, Meddings J, Collins SM; WEL Investigators. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004;20:1317-1322. [PMID: 15606393 DOI: 10.1111/j.1365-2036.2004.02284.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 180] [Article Influence: 11.9] [Reference Citation Analysis]
60 Jadallah KA, Nimri LF, Ghanem RA. Protozoan parasites in irritable bowel syndrome: A case-control study. World J Gastrointest Pharmacol Ther 2017;8:201-7. [PMID: 29152406 DOI: 10.4292/wjgpt.v8.i4.201] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Rodríguez-Fandiño O, Hernández-Ruíz J, López-Vidal Y, Charúa L, Bandeh-Moghaddam H, Minzoni A, Guzmán C, Schmulson M. Intestinal recruiting and activation profiles in peripheral blood mononuclear cells in response to pathogen-associated molecular patterns stimulation in patients with IBS. Neurogastroenterol Motil 2013;25:872-e699. [PMID: 23937411 DOI: 10.1111/nmo.12204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
62 Morken MH, Lind RA, Valeur J, Wilhelmsen I, Berstad A. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study. Scand J Gastroenterol. 2009;44:308-313. [PMID: 19031266 DOI: 10.1080/00365520802588091] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
63 Berumen A, Edwinson AL, Grover M. Post-infection Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:445-61. [PMID: 34024451 DOI: 10.1016/j.gtc.2021.02.007] [Reference Citation Analysis]
64 Collins SM, Chang C, Mearin F. Postinfectious Chronic Gut Dysfunction: From Bench to Bedside. Am J Gastroenterol Suppl 2012;1:2-8. [DOI: 10.1038/ajgsup.2012.2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
65 Marynowski M, Likońska A, Zatorski H, Fichna J. Role of environmental pollution in irritable bowel syndrome. World J Gastroenterol 2015;21:11371-8. [PMID: 26523104 DOI: 10.3748/wjg.v21.i40.11371] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
66 Lee YY, Annamalai C, Rao SSC. Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0595-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
67 Beyak MJ, Bulmer DC, Jiang W, Keating C, Rong W, Grundy D. Extrinsic Sensory Afferent Nerves Innervating the Gastrointestinal Tract. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 685-725. [DOI: 10.1016/b978-012088394-3/50028-3] [Cited by in Crossref: 16] [Article Influence: 1.1] [Reference Citation Analysis]
68 Costedio MM, Coates MD, Danielson AB, Buttolph TR, Blaszyk HJ, Mawe GM, Hyman NH. Serotonin signaling in diverticular disease. J Gastrointest Surg. 2008;12:1439-1445. [PMID: 18491196 DOI: 10.1007/s11605-008-0536-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
69 Spiller RC. Infection, immune function, and functional gut disorders. Clinical Gastroenterology and Hepatology 2004;2:445-55. [DOI: 10.1016/s1542-3565(04)00159-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
70 McLaughlin J, Houghton LA. The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. Expert Opin Drug Saf. 2006;5:313-327. [PMID: 16503751 DOI: 10.1517/14740338.5.2.313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
71 Sanchez-Ruiz M, Brunn A, Montesinos-Rongen M, Rudroff C, Hartmann M, Schlüter D, Pfitzer G, Deckert M. Enteric Murine Ganglionitis Induced by Autoimmune CD8 T Cells Mimics Human Gastrointestinal Dysmotility. Am J Pathol 2019;189:540-51. [PMID: 30593823 DOI: 10.1016/j.ajpath.2018.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
72 Riddle MS, Gutierrez RL, Verdu EF, Porter CK. The chronic gastrointestinal consequences associated with campylobacter. Curr Gastroenterol Rep. 2012;14:395-405. [PMID: 22864805 DOI: 10.1007/s11894-012-0278-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
73 Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, Garcia-Perez JE, Van Oudenhove L, Van Ranst M, Verhaegen J, Liston A, Boeckxstaens G. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65:1279-1288. [PMID: 26071133 DOI: 10.1136/gutjnl-2015-309460] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
74 Kumari MV, Amarasiri L, Rajindrajith S, Devanarayana NM. Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology? Expert Rev Gastroenterol Hepatol 2021;15:9-24. [PMID: 32909837 DOI: 10.1080/17474124.2020.1821652] [Reference Citation Analysis]
75 Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014;20:3976-3985. [PMID: 24744587 DOI: 10.3748/wjg.v20.i14.3976] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
76 Choudhury BK, Shi XZ, Sarna SK. Gene plasticity in colonic circular smooth muscle cells underlies motility dysfunction in a model of postinfective IBS. Am J Physiol Gastrointest Liver Physiol 2009;296:G632-42. [PMID: 19136376 DOI: 10.1152/ajpgi.90673.2008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
77 Lee EH, Yang HR, Lee HS. Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III Criteria. J Neurogastroenterol Motil 2016;22:459-69. [PMID: 27053514 DOI: 10.5056/jnm15174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
78 Mearin F, Balboa A. [Post-infectious functional gastrointestinal disorders: from the acute episode to chronicity]. Gastroenterol Hepatol 2011;34:415-21. [PMID: 21641686 DOI: 10.1016/j.gastrohep.2011.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
79 Khalil M, Zhang Z, Engel MA. Neuro-Immune Networks in Gastrointestinal Disorders. Visc Med 2019;35:52-60. [PMID: 31312651 DOI: 10.1159/000496838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
80 Grundy D, Schemann M. Serotonin in the gut: pretty when it gets down to the nitty gritty. Neurogastroenterol Motil 2004;16:507-9. [PMID: 15500506 DOI: 10.1111/j.1365-2982.2004.00573.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
81 Talley NJ. Irritable bowel syndrome. Intern Med J 2006;36:724-8. [PMID: 17040359 DOI: 10.1111/j.1445-5994.2006.01217.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
82 Goodwin L, Bourke JH, Forbes H, Hotopf M, Hull L, Jones N, Rona RJ, Wessely S, Fear NT. Irritable bowel syndrome in the UK military after deployment to Iraq: what are the risk factors? Soc Psychiatry Psychiatr Epidemiol 2013;48:1755-65. [PMID: 23636672 DOI: 10.1007/s00127-013-0699-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
83 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.2289/fphys.2011.00049.epub] [Reference Citation Analysis]
84 Ghoshal UC, Ranjan P. Post-infectious irritable bowel syndrome: the past, the present and the future. J Gastroenterol Hepatol. 2011;26 Suppl 3:94-101. [PMID: 21443719 DOI: 10.1111/j.1440-1746.2011.06643.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
85 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
86 Verdu EF, Riddle MS. Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis. Am J Gastroenterol 2012;107:981-9. [PMID: 22508147 DOI: 10.1038/ajg.2012.65] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
87 Yu XZ, Liu HF, Sun ZX. Investigation of the effect of military stress on the prevalence of functional bowel disorders. World J Gastroenterol. 2012;18:3004-3007. [PMID: 22736925 DOI: 10.3748/wjg.v18.i23.3004] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
88 Bafutto M, Almeida JR, Leite NV, Oliveira EC, Gabriel-Neto S, Rezende-Filho J. Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine. Arq Gastroenterol. 2011;48:36-40. [PMID: 21537540 DOI: 10.1590/s0004-28032011000100008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
89 Villani AC, Lemire M, Thabane M, Belisle A, Geneau G, Garg AX, Clark WF, Moayyedi P, Collins SM, Franchimont D. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology. 2010;138:1502-1513. [PMID: 20044998 DOI: 10.1053/j.gastro.2009.12.049] [Cited by in Crossref: 162] [Cited by in F6Publishing: 146] [Article Influence: 14.7] [Reference Citation Analysis]
90 Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ, Brady CA, Barnes NM, Schemann M. Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors. Gastroenterology. 2005;128:1317-1326. [PMID: 15887114 DOI: 10.1053/j.gastro.2005.02.005] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 4.3] [Reference Citation Analysis]
91 Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G, Spiller R. Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil. 2005;17:863-870. [PMID: 16336502 DOI: 10.1111/j.1365-2982.2005.00719.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 131] [Article Influence: 9.5] [Reference Citation Analysis]
92 demedts I, geboes K, kindt S, vanden berghe P, andrioli A, janssens J, tack J. Neural mechanisms of early postinflammatory dysmotility in rat small intestine. Neurogastroenterol Motil 2006;18:1102-11. [DOI: 10.1111/j.1365-2982.2006.00857.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
93 Kao KT, Pedraza BA, McClune AC, Rios DA, Mao YQ, Zuch RH, Kanter MH, Wirio S, Conteas CN. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009;15:3122-3127. [PMID: 19575491 DOI: 10.3748/wjg.15.3122] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
94 Schwille-Kiuntke J, Enck P, Polster AV, Gaile M, Kremsner PG, Zanger P. Postinfectious irritable bowel syndrome after travelers' diarrhea--a cohort study. Neurogastroenterol Motil 2015;27:1147-55. [PMID: 26009981 DOI: 10.1111/nmo.12601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
95 Moss-morris R, Spence M. To “Lump” or to “Split” the Functional Somatic Syndromes: Can Infectious and Emotional Risk Factors Differentiate Between the Onset of Chronic Fatigue Syndrome and Irritable Bowel Syndrome? Psychosomatic Medicine 2006;68:463-9. [DOI: 10.1097/01.psy.0000221384.07521.05] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
96 Barbara G, Grover M, Bercik P, Corsetti M, Ghoshal UC, Ohman L, Rajilić-Stojanović M. Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. Gastroenterology 2019;156:46-58.e7. [PMID: 30009817 DOI: 10.1053/j.gastro.2018.07.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 18.3] [Reference Citation Analysis]
97 Ma X, Wang X, Kang N, Chen T, Ji H, Lv L, Yin X, Tian Y, Zheng R, Duan Y, Wang F, Tang X. The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats. Evid Based Complement Alternat Med. 2017;2017:9086034. [PMID: 28331524 DOI: 10.1155/2017/9086034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
98 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 15.6] [Reference Citation Analysis]
99 El-Salhy M, Mazzawi T, Gundersen D, Hatlebakk JG, Hausken T. Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes 2013;6:391. [PMID: 24073715 DOI: 10.1186/1756-0500-6-391] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
100 Hughes PA, Brierley SM, Blackshaw LA. Post-inflammatory modification of colonic afferent mechanosensitivity. Clin Exp Pharmacol Physiol. 2009;36:1034-1040. [PMID: 19566823 DOI: 10.1111/j.1440-1681.2009.05248.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
101 Grover M, Camilleri M, Smith K, Linden DR, Farrugia G. On the fiftieth anniversary. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil. 2014;26:156-167. [PMID: 24438587 DOI: 10.1111/nmo.12304] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
102 Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. [PMID: 17267314 DOI: 10.1016/j.dld.2006.10.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
103 Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, Isaacs NJ, Maldeniya L, Martin CM, Persson J. Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut. 2012;Jul 27; Epub ahead of print. [PMID: 22767422 DOI: 10.1136/gutjnl-2011-301856] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 14.1] [Reference Citation Analysis]
104 Corazziari ES. Pathophysiological approach to chronic diarrhoea. Intern Emerg Med 2012;7 Suppl 3:S251-4. [PMID: 23073865 DOI: 10.1007/s11739-012-0820-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
105 Lomax AE, O’Hara JR, Hyland NP, Mawe GM, Sharkey KA. Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis. Am J Physiol Gastrointest Liver Physiol. 2007;292:G482-G491. [PMID: 17008554 DOI: 10.1152/ajpgi.00355.2006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
106 Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-1988. [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074] [Cited by in Crossref: 456] [Cited by in F6Publishing: 396] [Article Influence: 38.0] [Reference Citation Analysis]
107 Liu S, Shi Q, Zhu Q, Zou T, Li G, Huang A, Wu B, Peng L, Song M, Wu Q, Xie Q, Lin W, Xie W, Wen S, Zhang Z, Lv Q, Zou L, Zhang X, Ying M, Li G, Liang S. P2X₇ receptor of rat dorsal root ganglia is involved in the effect of moxibustion on visceral hyperalgesia. Purinergic Signal 2015;11:161-9. [PMID: 25527178 DOI: 10.1007/s11302-014-9439-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
108 Fjorback LO, Carstensen T, Arendt M, Ornbøl E, Walach H, Rehfeld E, Fink P. Mindfulness therapy for somatization disorder and functional somatic syndromes: analysis of economic consequences alongside a randomized trial. J Psychosom Res 2013;74:41-8. [PMID: 23272987 DOI: 10.1016/j.jpsychores.2012.09.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
109 Keating C, Pelegrin P, Martínez CM, Grundy D. P2X 7 Receptor-Dependent Intestinal Afferent Hypersensitivity in a Mouse Model of Postinfectious Irritable Bowel Syndrome. J I 2011;187:1467-74. [DOI: 10.4049/jimmunol.1100423] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
110 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
111 Brierley SM, Hughes PA, Page AJ, Kwan KY, Martin CM, O’Donnell TA, Cooper NJ, Harrington AM, Adam B, Liebregts T. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology. 2009;137:2084-2095.e3. [PMID: 19632231 DOI: 10.1053/j.gastro.2009.07.048] [Cited by in Crossref: 172] [Cited by in F6Publishing: 164] [Article Influence: 14.3] [Reference Citation Analysis]
112 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
113 Wood JD. Neuropathophysiology of the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 1643-68. [DOI: 10.1016/b978-0-12-809954-4.00067-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
114 Piche T. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome]. Gastroenterol Clin Biol. 2009;33 Suppl 1:S40-S47. [PMID: 19303538 DOI: 10.1016/S0399-8320(09)71524-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond) 2010;7:79. [PMID: 20939923 DOI: 10.1186/1743-7075-7-79] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
116 Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19:1638-1645. [PMID: 17013373 DOI: 10.1038/modpathol.3800704] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
117 Wang YM, Ge XZ, Wang WQ, Wang T, Cao HL, Wang BL, Wang BM. Lactobacillus rhamnosus GG supernatant upregulates serotonin transporter expression in intestinal epithelial cells and mice intestinal tissues. Neurogastroenterol Motil. 2015;27:1239-1248. [PMID: 26088715 DOI: 10.1111/nmo.12615] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
118 Futagami S, Itoh T, Sakamoto C. Systematic review with meta-analysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther. 2015;41:177-188. [PMID: 25348873 DOI: 10.1111/apt.13006] [Cited by in Crossref: 81] [Cited by in F6Publishing: 56] [Article Influence: 11.6] [Reference Citation Analysis]
119 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-230x-11-122] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
120 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155-168. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 24.5] [Reference Citation Analysis]
121 Kim DH, Cho YJ, Kim JH, Kim YB, Lee KJ. Stress-induced alterations in mast cell numbers and proteinase-activated receptor-2 expression of the colon: role of corticotrophin-releasing factor. J Korean Med Sci. 2010;25:1330-1335. [PMID: 20808677 DOI: 10.3346/jkms.2010.25.9.1330] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
122 Mearin F, Perelló A, Balboa A, Perona M, Sans M, Salas A, Angulo S, Lloreta J, Benasayag R, García-gonzalez MA, Pérez-oliveras M, Coderch J. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis. Scandinavian Journal of Gastroenterology 2009;44:1173-85. [DOI: 10.1080/00365520903171276] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
123 Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB. Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther. 2004;20:615-621. [PMID: 15352909 DOI: 10.1111/j.1365-2036.2004.02128.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
124 Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57:923-929. [PMID: 18252749 DOI: 10.1136/gut.2007.138982] [Cited by in Crossref: 316] [Cited by in F6Publishing: 276] [Article Influence: 24.3] [Reference Citation Analysis]
125 Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol. 2008;585:361-374. [PMID: 18417115 DOI: 10.1016/j.ejphar.2008.02.095] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
126 Keating C, Beyak M, Foley S, Singh G, Marsden C, Spiller R, Grundy D. Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism. J Physiol. 2008;586:4517-4530. [PMID: 18653657 DOI: 10.1113/jphysiol.2008.156984] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
127 Sun S, Liu W, Li Y. CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway. J Bioenerg Biomembr 2020;52:343-54. [PMID: 32929607 DOI: 10.1007/s10863-020-09850-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
128 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: org/10.1016/j.gtc.2005.02.007] [Reference Citation Analysis]
129 Spence MJ, Moss-Morris R. The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis. Gut 2007;56:1066-71. [PMID: 17324974 DOI: 10.1136/gut.2006.108811] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 6.9] [Reference Citation Analysis]
130 Koo HL, DuPont HL. Current and future developments in travelers' diarrhea therapy. Expert Rev Anti Infect Ther 2006;4:417-27. [PMID: 16771619 DOI: 10.1586/14787210.4.3.417] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
131 Lee C, Doo E, Choi JM, Jang SH, Ryu HS, Lee JY, Oh JH, Park JH, Kim YS; Brain-Gut Axis Research Group of Korean Society of Neurogastroenterology and Motility. The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil 2017;23:349-62. [PMID: 28672433 DOI: 10.5056/jnm16220] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 19.5] [Reference Citation Analysis]
132 Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007;19:62-88. [PMID: 17280586 DOI: 10.1111/j.1365-2982.2006.00875.x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 230] [Article Influence: 17.4] [Reference Citation Analysis]
133 Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008;20 Suppl 1:121-129. [PMID: 18402649 DOI: 10.1111/j.1365-2982.2008.01097.x] [Cited by in Crossref: 173] [Cited by in F6Publishing: 139] [Article Influence: 13.3] [Reference Citation Analysis]
134 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 102] [Article Influence: 11.9] [Reference Citation Analysis]
135 Fouad YM, Makhlouf MM, Khalaf H, Mostafa Z, Abdel Raheem E, Meneasi W. Is irritable bowel syndrome associated with chronic hepatitis C? J Gastroenterol Hepatol. 2010;25:1285-1288. [PMID: 20594257 DOI: 10.1111/j.1440-1746.2010.06311.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
136 Wang H, Gong J, Wang W, Long Y, Fu X, Fu Y, Qian W, Hou X. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One. 2014;9:e90153. [PMID: 24595218 DOI: 10.1371/journal.pone.0090153] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 7.3] [Reference Citation Analysis]
137 Nasser Y, Boeckxstaens GE, Wouters MM, Schemann M, Vanner S. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:455-469. [PMID: 24602069 DOI: 10.1111/nmo.12316] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
138 Shen B, Sanmiguel C, Bennett AE, Lian L, Larive B, Remzi FH, Fazio VW, Soffer EE. Irritable pouch syndrome is characterized by visceral hypersensitivity: . Inflammatory Bowel Diseases 2011;17:994-1002. [DOI: 10.1002/ibd.21412] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
139 Christmas DM, Badawy AA, Hince D, Davies SJ, Probert C, Creed T, Smithson J, Afzal M, Nutt DJ, Potokar JP. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome. Nutrition Research 2010;30:678-88. [DOI: 10.1016/j.nutres.2010.09.009] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
140 David LE, Surdea-Blaga T, Dumitrascu DL. Semiquantitative fecal calprotectin test in postinfectious and non-postinfectious irritable bowel syndrome: cross-sectional study. Sao Paulo Med J 2015;133:343-9. [PMID: 26039537 DOI: 10.1590/1516-3180.2014.8000815] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
141 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.13.6041] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
142 Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-661. [PMID: 15324705 DOI: 10.1016/j.bpg.2004.04.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 4.1] [Reference Citation Analysis]
143 Spiller RC. Potential future therapies for Irritable Bowel Syndrome: Will Disease Modifying Therapy as Opposed to Symptomatic Control Become a Reality? Gastroenterology Clinics of North America 2005;34:337-54. [DOI: 10.1016/j.gtc.2005.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
144 Aboubakr A, Cohen MS. Functional Bowel Disease. Clin Geriatr Med 2021;37:119-29. [PMID: 33213766 DOI: 10.1016/j.cger.2020.08.009] [Reference Citation Analysis]
145 Spiller RC. Irritable bowel syndrome. Br Med Bull. 2004;72:15-29. [PMID: 15767561 DOI: 10.1093/bmb/ldh039] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
146 La JH, Sung TS, Kim HJ, Kim TW, Kang TM, Yang IS. Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats. World J Gastroenterol. 2008;14:731-736. [PMID: 18205263 DOI: 10.3748/wjg.14.731] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
147 Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arq Gastroenterol. 2013;50:304-309. [PMID: 24474234 DOI: 10.1590/s0004-28032013000400012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
148 Forshammar J, Isaksson S, Strid H, Stotzer PO, Sjövall H, Simrén M, Ohman L. A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1461-1466. [PMID: 18663666 DOI: 10.1080/00365520802272126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
149 Lee YJ, Park KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol 2014;20:2456-69. [PMID: 24627583 DOI: 10.3748/wjg.v20.i10.2456] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 55] [Article Influence: 12.8] [Reference Citation Analysis]
150 Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol 2014;49:545-51. [PMID: 24646319 DOI: 10.3109/00365521.2014.886718] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
151 Cuomo R, Savarese MF, Gargano R. Almost All Irritable Bowel Syndromes Are Post-Infectious and Respond to Probiotics: Consensus Issues. Dig Dis 2007;25:241-4. [DOI: 10.1159/000103893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
152 Limsui D, Pardi DS, Camilleri M, Loftus EV, Kammer PP, Tremaine WJ, Sandborn WJ. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175-181. [PMID: 17206699 DOI: 10.1002/ibd.20059] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
153 Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-1294. [PMID: 16771951 DOI: 10.1111/j.1572-0241.2006.00672.x] [Cited by in Crossref: 311] [Cited by in F6Publishing: 298] [Article Influence: 20.7] [Reference Citation Analysis]
154 Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38-46. [PMID: 16374257 DOI: 10.1097/01.mib.0000195391.49762.89] [Cited by in Crossref: 198] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
155 Campaniello MA, Harrington AM, Martin CM, Ashley Blackshaw L, Brierley SM, Hughes PA. Activation of colo-rectal high-threshold afferent nerves by Interleukin-2 is tetrodotoxin-sensitive and upregulated in a mouse model of chronic visceral hypersensitivity. Neurogastroenterol Motil. 2016;28:54-63. [PMID: 26468044 DOI: 10.1111/nmo.12696] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
156 van Hoboken EA, Thijssen AY, Verhaaren R, van der Veek PP, Prins FA, Verspaget HW, Masclee AA. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity. Scand J Gastroenterol. 2011;46:981-987. [PMID: 21623672 DOI: 10.3109/00365521.2011.579156] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
157 Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr. 2007;45 Suppl 2:S115-S119. [PMID: 18185071 DOI: 10.1097/mpg.0b013e31812e66da] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
158 Nakane S, Mukaino A, Ihara E, Ogawa Y. Autoimmune gastrointestinal dysmotility: the interface between clinical immunology and neurogastroenterology. Immunological Medicine 2021;44:74-85. [DOI: 10.1080/25785826.2020.1797319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
159 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
160 Asproudis I, Tsoumani AT, Katsanos KH, Katsanos AH, Theopistos V, Paschidis KA, Tsianos EV, Christodoulou D. Irritable bowel syndrome might be associated with dry eye disease. Ann Gastroenterol 2016;29:487-91. [PMID: 27708515 DOI: 10.20524/aog.2016.0064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Donnachie E, Schneider A, Mehring M, Enck P. Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data. Gut 2018;67:1078-86. [DOI: 10.1136/gutjnl-2017-313713] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
162 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
163 Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Chae SW. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil. 2013;19:244-250. [PMID: 23667756 DOI: 10.5056/jnm.2013.19.2.244] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
164 Sundin J, Nordlander S, Eutamene H, Alquier‐bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
165 Parida PK, Mishra D, Pati GK, Nath P, Dash KR, Behera SK, Parida S, Khatua CR, Panigrahi S, Mahapatra A, Khuntia HK, Singh SP. A prospective study on incidence, risk factors, and validation of a risk score for post-infection irritable bowel syndrome in coastal eastern India. Indian J Gastroenterol 2019;38:134-42. [DOI: 10.1007/s12664-019-00943-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
166 Hong KB, Seo H, Lee JS, Park Y. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model. BMC Complement Altern Med 2019;19:195. [PMID: 31366385 DOI: 10.1186/s12906-019-2610-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
167 Craig OF, Quigley EM. Bacteria, genetics and irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2010;4:271-6. [PMID: 20528114 DOI: 10.1586/egh.10.31] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
168 Hons IM, Burda JE, Grider JR, Mawe GM, Sharkey KA. Alterations to enteric neural signaling underlie secretory abnormalities of the ileum in experimental colitis in the guinea pig. Am J Physiol Gastrointest Liver Physiol 2009;296:G717-26. [PMID: 19221017 DOI: 10.1152/ajpgi.90472.2008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
169 Collins SM. The Relationship of Enteric Microbial Infection and Functional Bowel Disorders. Journal of Clinical Gastroenterology 2007;41:S30-2. [DOI: 10.1097/mcg.0b013e31802db351] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
170 Róka R, Ait-Belgnaoui A, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Eutamène H, Bueno L. Dexamethasone prevents visceral hyperalgesia but not colonic permeability increase induced by luminal protease-activated receptor-2 agonist in rats. Gut. 2007;56:1072-1078. [PMID: 17309885 DOI: 10.1136/gut.2006.115352] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
171 López-gómez L, Bagüés A, Uranga JA, Abalo R. Preclinical models of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome. Elsevier; 2020. pp. 233-76. [DOI: 10.1016/b978-0-12-821324-7.00012-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Walker MM, Talley NJ, Prabhakar M, Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS, Zinsmeister AR, Agreus L. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther. 2009;29:765-773. [PMID: 19183150 DOI: 10.1111/j.1365-2036.2009.03937.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 154] [Article Influence: 13.8] [Reference Citation Analysis]
173 Kanazawa M, Palsson OS, van Tilburg MA, Gangarosa LM, Fukudo S, Whitehead WE. Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil. 2014;26:696-704. [PMID: 24602083 DOI: 10.1111/nmo.12318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
174 Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Journal of Gastroenterology and Hepatology 2008;23:1689-94. [DOI: 10.1111/j.1440-1746.2008.05574.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
175 Lakhan SE, Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J Neuroinflammation. 2010;7:37. [PMID: 20615234 DOI: 10.1186/1742-2094-7-37] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 10.1] [Reference Citation Analysis]
176 O’malley D, Quigley EM, Dinan TG, Cryan JF. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain, Behavior, and Immunity 2011;25:1333-41. [DOI: 10.1016/j.bbi.2011.04.009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
177 Kellow JE, Azpiroz F, Delvaux M, Gebhart GF, Mertz HR, Quigley EM, Smout AJ. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006;130:1412-1420. [PMID: 16678555 DOI: 10.1053/j.gastro.2005.08.061] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
178 Ruigómez A, García Rodríguez LA, Panés J. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities. Clin Gastroenterol Hepatol 2007;5:465-9. [PMID: 17445753 DOI: 10.1016/j.cgh.2007.02.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
179 Dunlop SP, Jenkins D, Spiller RC. Age-related decline in rectal mucosal lymphocytes and mast cells: . European Journal of Gastroenterology & Hepatology 2004;16:1011-5. [DOI: 10.1097/00042737-200410000-00010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
180 Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2007;9:378-384. [PMID: 17991338 DOI: 10.1007/s11894-007-0046-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
181 Aziz I, Evans KE, Hopper AD, Smillie DM, Sanders DS. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther. 2010;32:1392-1397. [PMID: 21050242 DOI: 10.1111/j.1365-2036.2010.04477.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 6.7] [Reference Citation Analysis]
182 Scarpellini E, Giorgio V, Gabrielli M, Lauritano E, Pantanella A, Fundarò C, Gasbarrini A. Prevalence of Small Intestinal Bacterial Overgrowth in Children with Irritable Bowel Syndrome: A Case-Control Study. The Journal of Pediatrics 2009;155:416-20. [DOI: 10.1016/j.jpeds.2009.03.033] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
183 Downs IA, Aroniadis OC, Kelly L, Brandt LJ. Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease. J Clin Gastroenterol 2017;51:869-77. [PMID: 28885302 DOI: 10.1097/MCG.0000000000000924] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
184 Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129:98-104. [PMID: 16012939 DOI: 10.1053/j.gastro.2005.04.012] [Cited by in Crossref: 270] [Cited by in F6Publishing: 224] [Article Influence: 16.9] [Reference Citation Analysis]
185 Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol. 2009;15:3591-3596. [PMID: 19653335 DOI: 10.3748/wjg.15.3591] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
186 Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol. 2009;104:1205-1212. [PMID: 19367268 DOI: 10.1038/ajg.2009.116] [Cited by in Crossref: 101] [Cited by in F6Publishing: 97] [Article Influence: 8.4] [Reference Citation Analysis]
187 Zhang Z, Engel MA, Koch E, Reeh PW, Khalil M. Menthacarin induces calcium ion influx in sensory neurons, macrophages and colonic organoids of mice. Life Sci 2021;264:118682. [PMID: 33127519 DOI: 10.1016/j.lfs.2020.118682] [Reference Citation Analysis]
188 Rhodes DY, Wallace M. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2006;8:327-332. [PMID: 16836945 DOI: 10.1007/s11894-006-0054-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
189 Nair P, Okhuysen PC, Jiang ZD, Carlin LG, Belkind-Gerson J, Flores J, Paredes M, DuPont HL. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med 2014;21:153-8. [PMID: 24621006 DOI: 10.1111/jtm.12114] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
190 Camilleri M. Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol Motil. 2005;17:311-316. [PMID: 15916617 DOI: 10.1111/j.1365-2982.2004.00632.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
191 Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis 2011;24:503-8. [PMID: 21844806 DOI: 10.1097/QCO.0b013e32834a962d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
192 Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349-357. [PMID: 15822040 DOI: 10.1016/s1542-3565(04)00726-8] [Cited by in Crossref: 222] [Cited by in F6Publishing: 108] [Article Influence: 13.9] [Reference Citation Analysis]
193 Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 2008;20 Suppl 1:73-80. [PMID: 18402644 DOI: 10.1111/j.1365-2982.2008.01110.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
194 Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42 Suppl 17:41-47. [PMID: 17238025 DOI: 10.1007/s00535-006-1925-8] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 8.7] [Reference Citation Analysis]
195 Sibelli A, Chalder T, Everitt H, Workman P, Windgassen S, Moss-morris R. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset. Psychol Med 2016;46:3065-80. [DOI: 10.1017/s0033291716001987] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 13.6] [Reference Citation Analysis]
196 Törnblom H, Abrahamsson H, Barbara G, Hellström PM, Lindberg G, Nyhlin H, Ohlsson B, Simrèn M, Sjölund K, Sjövall H, Schmidt PT, Öhman L, Group TSM. Inflammation as a cause of functional bowel disorders. Scandinavian Journal of Gastroenterology 2005;40:1140-8. [DOI: 10.1080/00365520510023657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
197 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012. 18.3.258] [Reference Citation Analysis]
198 Pimentel M, Chang C. Inflammation and microflora. Gastroenterol Clin North Am. 2011;40:69-85. [PMID: 21333901 DOI: 10.1016/j.gtc.2010.12.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
199 Han W, Lu X, Jia X, Zhou T, Guo C. Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species. Dig Dis Sci. 2012;57:311-319. [PMID: 21901252 DOI: 10.1007/s10620-011-1897-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
200 Ahmad OF, Akbar A. Microbiome, antibiotics and irritable bowel syndrome. Br Med Bull 2016;120:91-9. [DOI: 10.1093/bmb/ldw038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
201 Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut. 2013;62:985-994. [PMID: 22684480 DOI: 10.1136/gutjnl-2011-301213] [Cited by in Crossref: 105] [Cited by in F6Publishing: 97] [Article Influence: 11.7] [Reference Citation Analysis]
202 Lee JW, Park JH, Park DIL, Park J, Kim HJ, Cho YK, Sohn CIL, Jeon WK, Kim BI. Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase. Dig Dis Sci 2010;55:2922-8. [DOI: 10.1007/s10620-009-1094-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
203 Jung IS, Kim HS, Park H, Lee SI. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol. 2009;43:534-540. [PMID: 19262407 DOI: 10.1097/MCG.0b013e31818c87d7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 3.1] [Reference Citation Analysis]
204 Almansa C, Agrawal A, Houghton LA. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:383-398. [PMID: 22646259 DOI: 10.1586/egh.12.9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
205 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 10.9] [Reference Citation Analysis]
206 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
207 M. RA. DIARREA AGUDA. Revista Médica Clínica Las Condes 2015;26:676-86. [DOI: 10.1016/j.rmclc.2015.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
208 Pregun I, Herszényi L, Juhász M, Miheller P, Tulassay Z. Novel therapeutic approaches in the treatment of irritable bowel syndrome. Orvosi Hetilap 2007;148:923-8. [DOI: 10.1556/oh.2007.27995] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
209 Locke GR, Lin S, Talley NJ. Psychiatric Disease and Functional GI Disorders in the Community: More Evidence for a Casual Link? Am J Gastroenterology 2005;100:248-9. [DOI: 10.1111/j.1572-0241.2005.41277_3.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
210 Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18:6-17. [PMID: 16371078 DOI: 10.1111/j.1365-2982.2005.00685.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
211 Lalani T, Maguire JD, Grant EM, Fraser J, Ganesan A, Johnson MD, Deiss RG, Riddle MS, Burgess T, Tribble DR; IDCRP TravMil Study Group. Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries. J Travel Med 2015;22:152-60. [PMID: 25483360 DOI: 10.1111/jtm.12179] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
212 von Volkmann HL, Brønstad I, Tronstad RR, Dizdar V, Nylund K, Hanevik K, Hausken T, Gilja OH, Fiskerstrand T. Plasma levels of guanylins are reduced in patients with Crohn's disease. Scand J Gastroenterol 2020;55:449-53. [PMID: 32306784 DOI: 10.1080/00365521.2020.1748224] [Reference Citation Analysis]
213 Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22:13-17. [PMID: 16319671 DOI: 10.1097/01.mog.0000194792.36466.5c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
214 Hu X, Zhang X, Han B, Bei W. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor. BMC Complement Altern Med. 2013;13:246. [PMID: 24088410 DOI: 10.1186/1472-6882-13-246] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
215 Mearin F. Editorial: From the acute infection to the chronic disorder "Don't worry it's just a viral gastroenteritis". Am J Gastroenterol 2012;107:900-1. [PMID: 22664848 DOI: 10.1038/ajg.2012.105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF, Zaitoun A, Montgomery A, Spiller RC. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Efficacy Mech Eval 2015;2:1-62. [DOI: 10.3310/eme02020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
217 Han W, Wang Z, Lu X, Guo C. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:113-19, e82. [PMID: 22151913 DOI: 10.1111/j.1365-2982.2011.01841.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
218 De Giorgio R, Barbara G. Is irritable bowel syndrome an inflammatory disorder? Curr Gastroenterol Rep. 2008;10:385-390. [PMID: 18627650 DOI: 10.1007/s11894-008-0073-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
219 Connor BA. Sequelae of traveler’s diarrhea: focus on postinfectious irritable bowel syndrome. Clin Infect Dis. 2005;41 Suppl 8:S577-S586. [PMID: 16267722 DOI: 10.1086/432956] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
220 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 12.1] [Reference Citation Analysis]
221 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.3389/fphys.2011.00049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
222 Guagnozzi D, Arias Á, Lucendo AJ. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders. Aliment Pharmacol Ther 2016;43:851-62. [DOI: 10.1111/apt.13573] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]